The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1b/2 study of nanatinostat and valganciclovir in patients with advanced Epstein-Barr virus positive (EBV+) solid tumors and in combination with pembrolizumab in patients with recurrent/metastatic nasopharyngeal carcinoma (RM-NPC).
 
A. Dimitrios Colevas
Consulting or Advisory Role - Alpha BioCom; Beigene; ClearView Healthcare Partners; Deallus; Gilead Sciences; leidos biomedical research
Research Funding - Abbvie; AstraZeneca; Atara Biotherapeutics; BioNtech; BMS; CUE Biopharma; Cullinan Oncology; Exelixis; Experimental Therapeutics Clinical Trials Network (ETCTN); Forty Seven; Innate Pharma; Merck; NIH/NCI; NRG Oncology; Tessa Therapeutics
 
Lillian L. Siu
Leadership - Treadwell Therapeutics (I)
Stock and Other Ownership Interests - Agios (I)
Consulting or Advisory Role - Amgen; Arvinas; AstraZeneca/MedImmune; Daiichi Sankyo/UCB Japan; GlaxoSmithKline; Hookipa Pharma; InterRNA; Janpix; Janssen; Merck; Navire; Oncorus; Relay Therapeutics; Roche; Sanofi; Seagen; Tessa Therapeutics; Voronoi Health Analytics
Research Funding - Amgen (Inst); Amgen (Inst); Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); AVID Radiopharmaceuticals (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Intensity Therapeutics (Inst); Karyopharm Therapeutics (Inst); Merck (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Shattuck Labs (Inst); Symphogen (Inst)
 
Darren Wan-Teck Lim
Consulting or Advisory Role - AstraZeneca/MedImmune/Spirogen; Boehringer Ingelheim; MSD Oncology; Roche
Research Funding - Bristol-Myers Squibb (Inst)
 
Bo Gao
Consulting or Advisory Role - BeiGene; MSD
 
Lisa Rojkjaer
Employment - Viracta Therapeutics
Leadership - Viracta Therapeutics
Stock and Other Ownership Interests - Viracta Therapeutics
 
Afton Katkov
Employment - Viracta Therapeutics
Stock and Other Ownership Interests - Viracta Therapeutics
 
Yisrael Katz
Employment - Exelixis
Stock and Other Ownership Interests - Exelixis
 
Brigette Ma
Honoraria - Merck Serono; Merck Sharp & Dohme; Novartis; Roche
Consulting or Advisory Role - BMS Taiwan; Merck Sharp & Dohme; Novartis; Viracta Therapeutics; Viracta Therapeutics; Y-biologics
Research Funding - Boehringer Ingelheim; Merck Serono; Novartis
Travel, Accommodations, Expenses - Merck Serono